Epelde F, Garca-Castrillo Riesgo L, Loma-Osorio A, Verdier J, Recuerda Martnez E
Med Clin (Barc). 2000 Oct 14;115(12):455-7. doi: 10.1016/s0025-7753(00)71590-9.
Acetyl salicylic acid is a drug with demonstrated effectiveness in ischemic cardiomyopathy. The objective of our study was to know the use of this drug in the emergency services of Spain.
The EVICURE study analyzes the use of acetyl salicylic acid in 35 emergency services of Spanish hospitals.
2,168 patients were studied. Of the 473 patients with stable angina, 9.2% received acetyl salicylic acid before going to the hospital and 90,7% at the arrival to the hospital, of 1,067 with unstable angina 13% received acetyl salicylic acid before the arrival to the hospital and 56% at the arrival to the hospital. Of 600 patients affected of myocardial infarction only 17% received acetyl salicylic acid before the arrival to the hospital and 59.8% received this drug in the emergency room.
The use of acetyl salicylic acid in patients affected of ischemic cardiopathy assisted in the emergency services of Spain is improperly low.
乙酰水杨酸是一种在缺血性心肌病中已证实有疗效的药物。我们研究的目的是了解该药物在西班牙急救服务中的使用情况。
EVICURE研究分析了西班牙医院35个急救服务机构中乙酰水杨酸的使用情况。
共研究了2168例患者。在473例稳定型心绞痛患者中，9.2%在入院前接受了乙酰水杨酸治疗，90.7%在入院时接受了治疗；在1067例不稳定型心绞痛患者中，13%在入院前接受了乙酰水杨酸治疗，56%在入院时接受了治疗。在600例心肌梗死患者中，只有17%在入院前接受了乙酰水杨酸治疗，59.8%在急诊室接受了该药物治疗。
在西班牙急救服务机构就诊的缺血性心脏病患者中，乙酰水杨酸的使用比例过低。
